Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | An overview of the biology of WHIM syndrome

David Dale • 10 Jun 2022
EHA 2022
Rare Diseases WHIM Syndrome

David Dale, MD, University of Washington, Seattle, WA, summarizes the biology of WHIM syndrome, a disease that affects the CXCR4 gene and results in low white blood cell count and susceptibility to infections. Prof This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from David Dale

0:46
Diagnosis and treatment of neutropenia
David Dale • 10 Jun 2022
0:34
4WHIM study: safety & efficacy of mavorixafor in patients with WHIM syndrome
David Dale • 10 Jun 2022

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals